Navigation Links
Option to Develop Exelixis Compound Exercised By Genentech
Date:3/14/2008

SOUTH SAN FRANCISCO, Calif., March 14 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL) today announced that Genentech, Inc. has exercised its option to further develop and commercialize Exelixis' compound XL518, a selective and potent inhibitor of MEK, which is currently in a phase 1 clinical trial. Under the terms of the collaboration agreement between the parties, Exelixis will continue to be responsible for the phase 1 clinical trial until the point that a maximum tolerated dose (MTD) is determined. After MTD is achieved, Genentech will be responsible for completing the phase 1 clinical trial and subsequent clinical development.

"MEK inhibition is an exciting approach to cancer therapy. The MAP kinase pathway, of which MEK is a member, is one of the most frequently dysregulated pathways in human tumors. Activating mutations of the pathway have been identified in many tumor types, including melanomas, thyroid carcinomas, non-small cell lung cancer and colon cancer. Pathway inhibitors are likely to find broad utility as both single agents and in combination with other targeted agents and chemotherapeutics," said George A. Scangos, PhD, president and chief executive officer of Exelixis. "I am pleased that Genentech shares our interest in the target and the compound. We believe the opt-in by Genentech is recognition of the potential of XL518 and MEK inhibition in the treatment of various tumor types," continued Dr. Scangos.

Under the terms of the collaboration agreement between Exelixis and Genentech, Exelixis received upfront and milestone payments totaling $40.0 million at the time the agreement was signed in January 2007. Selection of the compound and opt-in by Genentech trigger a payment of $3.0 million. Another $7
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Angiotech and Rex Medical announce exclusive licensing and distribution agreement for the "Option(TM)" inferior vena cava filter
2. Micromet to Present at the Susquehanna Financial Groups SIGnificant Investment Options Conference on March 4, 2008
3. Kosan Biosciences to Present at the Susquehanna Second Annual SIGnificant Options in Healthcare Conference
4. Exelixis Announces March 4 Webcast of Presentation at the Susquehanna SIGnificant Options in Healthcare Conference
5. InterMune to Present at the SIGnificant Options in Healthcare Conference
6. ViroPharma to Present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference
7. Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference
8. Pharmasset to Present at Susquehannas Second Annual SIGnificant Investment Options in Healthcare Conference on Wednesday, March 5th
9. TorreyPines Therapeutics to Present at Susquehanna Financial Groups Second Annual SIGnificant Options in Healthcare Conference
10. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
11. Isis Announces Equity Investment in Ibis Biosciences Subsidiary by Abbott; Option Acquired to Purchase Remaining Ibis Equity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014 NCERC at ... will present his findings on corn stover pretreatment ... this week in Washington, D.C. , “Arun’s ... conference is a testament to the success of ... said. “Thanks to the foresight and vision of ...
(Date:7/30/2014)... CA (PRWEB) July 30, 2014 Adding ... their weighing boat special – Buy 2 ... free. This promotion will benefit lab technicians looking for ... Weighing boats are ideal for multiple applications including weighing ... a variety of choices including diamond-shaped, hexagonal, square, aluminum ...
(Date:7/29/2014)... SoundConnect , an award ... proud to announce the strategic additions of implementation, ... Boston, Charleston and Atlanta offices. SoundConnect’s organizational ... for hosted solutions, collaboration and mobility that improve ... , SoundConnect was founded in 2004, with the ...
(Date:7/29/2014)... Bellingham, WA (PRWEB) July 29, 2014 ... manipulation of the brain that are driving a revolution ... a new peer-reviewed journal published by SPIE, ... The first issue coincides with the launch of the ... section features articles that lay out a vision for ...
Breaking Biology Technology:NCERC at SIUE Researcher Takes Stage at Department of Energy Conference 2NCERC at SIUE Researcher Takes Stage at Department of Energy Conference 3Weighing Boat Promotion Now Available at Pipette.com, Major Pipette Distributor 2SoundConnect Organization and Culture is Evolving 2SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 2SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 3SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 4
... two days of demostrating Wisconsin's breakthroughs in biotechnology, the ... with a discussion of what the state must do to ... strides Wisconsin has made in research, but explained without capital ... Still, moderator of the panel and president of the ...
... observed that many IT shops get stuck in the ... While I have been known to scramble up on a soapbox to ... for machine under desk. , ,The problem my friend is pointing out ... their desk without the first concern for reliability, security, connectivity or compatibility. ...
... Vogel, Department of Health and Human Services; Tom Still, ... and Human Services and park warden at Arusha National ... Arusha, Tanzania Even if former Wisconsin Gov. ... administration, his legacy at the Department of Health of ...
Cached Biology Technology:Out-of-state VCs offer advice on biotech investments 2Out-of-state VCs offer advice on biotech investments 3Is your IT stuck in the MUD? 2Is your IT stuck in the MUD? 3Thompson's HHS legacy will include efforts to combat disease in Africa 2Thompson's HHS legacy will include efforts to combat disease in Africa 3
(Date:7/30/2014)... infection could be as simple as inserting a medicated, ... of Washington bioengineers have discovered a potentially faster way ... contracting HIV. Their method spins the drug into silk-like ... releasing higher doses of the drug than possible with ... "This could offer women a potentially more effective, discreet ...
(Date:7/30/2014)... , July 30, 2014 NexID ... and liveness detection solutions for the biometric authentication ... industry consortium revolutionizing online authentication with standards for ... Cornett , "The decision to join FIDO Alliance ... authentication pervasive in use. We believe the FIDO ...
(Date:7/30/2014)... Portland Press Limited today announced an across-the-board increase ... , The 2013 InCites Journal Citation Reports (Thomson ... Biochemical Journal , Essays in Biochemistry ... Bioscience Reports all received increases in their ... Biochemical Society and published by Portland Press Limited. ...
Breaking Biology News(10 mins):Dissolvable fabric loaded with medicine might offer faster protection against HIV 2Dissolvable fabric loaded with medicine might offer faster protection against HIV 3NexID Biometrics Joins the FIDO Alliance 2Across-the-board Impact Factor increases for Portland Press Limited 2
... valued for their aesthetic nature and their environmental ... A single mature tree can add considerable value ... can result in significant economic losses. Urban trees ... structural strength and subject them to stresses, predisposing ...
... trees provide a significant source of revenue in ... sales during the holiday buying season. The most ... appreciated for its fragrance and consumer-friendly traits such ... and natural Christmas tree shape. Frasers, indigenous to ...
... BUDAPEST, HUNGARY Apricots are important to Turkey, the ... than anywhere in the world. Looking to unlock the ... are studying the genetic relationship between apricot varieties. New ... has confirmed the genetic link between Turkish and Hungarian ...
Cached Biology News:Landscape tree disease from 12 wood decay fungi studied 2April grafting optimal for Fraser fir 2Genetic relationship between Hungarian and Turkish apricots confirmed 2
Mouse polyclonal antibody raised against a partial recombinant AGTRAP. NCBI Entrez Gene ID = 57085...
Mouse monoclonal antibody raised against a partial recombinant RAB11B. NCBI Entrez Gene ID = RAB11B...
... polyclonal antibody raised against a ... Immunogen: SF3B2 (NP_006833, ... partial recombinant protein with GST ... Number: NM_006842 ...
...
Biology Products: